Today, peer-reviewed results from a Phase 3 efficacy trial of the R21/Matrix-M™ malaria vaccine were published in The Lancet. The study was conducted across multiple sites in four African countries with 4,800…

University of Virginia scientists have developed a new approach to machine learning – a form of artificial intelligence – to identify drugs that help minimize harmful scarring after a heart…

The Medicines and Healthcare products Regulatory Agency (MHRA) has designated two new UK Approved Bodies, delivering increased capacity for the certification of the performance and safety of medical devices, for…

Almirall S.A., a global pharmaceutical company focused on medical dermatology, announced today a strategic partnership with Microsoft to drive innovation and digital transformation, advance the research of medical solutions for dermatological…

Where you live must not determine how long you live. Regular testing is needed to end the postcode health lottery, says a leading expert.

Most family doctors surveyed fear that giving patients online access to their medical records will increase their workload and the risks of litigation, suggest the results of the largest study…

eLabNext (an Eppendorf Group Company), the provider of a Digital Lab Platform with lab inventory management system (LIMS), electronic lab notebook (ELN), and artificial intelligence (AI)/machine learning (ML) solutions for life…

Researchers uncover that the Xist ribonucleoprotein complex, unique to females, is a key driver of sex-biased autoimmunity, offering new insights into autoimmune disorders' higher prevalence in women.

Ramadan fasting significantly reduces the risk of lung, colorectal, and breast cancers, showcasing beneficial metabolic changes through a comprehensive metabolomics investigation.

Study reveals ethnic and racial disparities in health outcomes post-COVID-19 infection, with Hispanic and racial minority groups reporting poorer health status and increased work absence compared to their non-Hispanic and…